RecruitingNCT03273049
Mapping Disease Pathways for Biliary Atresia
Coordinating Center- Mapping Disease Pathways for Biliary Atresia
Sponsor
University of Pittsburgh
Enrollment
1,100 participants
Start Date
Jul 21, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.
Eligibility
Inclusion Criteria1
- living individuals who were diagnosed with Biliary Atresia and received or are about to receive a liver transplant from multiple participating centers (Children's Hospital of Pittsburgh, Kings College Hospital, Children's Hospital of Birmingham, and Hospital Sírio-Libanês).
Exclusion Criteria1
- No child participant in the care of the state will be enrolled, nor will patients in the care of temporary or informal guardians be enrolled
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03273049
Related Trials
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
NCT050726261 location
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
NCT058483101 location
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
NCT072508541 location
Nutritional Intervention for Biliary Atresia
NCT067640821 location
Biliary Atresia Study in Infants and Children
NCT0034555316 locations